Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIC5-15 in Alzheimer's Disease
NCT01928420Phase 2Completed
- Sponsor
- Humanetics
- Start
- Apr 2007
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pinitol in Alzheimer's disease (AD), sponsored by Humanetics. Started Apr 2007; status: completed.
02
Drugs
pinitol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01928420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928420.